# Forensic Dossier: Study Forensics: Amyloid-targeting antibody improves biomarkers without cognitive benefit

**Run ID:** `full27_study-forensics-029_Claude_Opus_14675e`  
**Task:** study-forensics-029 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T18:02:02.574064+00:00  
**Task Family:** solid  
**Trap Type:** borderline_solid_with_caveats  
**Ambiguity:** medium  

## Executive Summary

**Agents tested:** Claude Opus
**Winner:** Claude Opus — **69.3/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step
**Forensic flags:** 4
**Consistency findings:** 8
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Opus | 30.0/30 | 0.0/8 | 4.8/8 | 4.8/6 | 3.6/6 | 4.5/6 | 3.6/8 | 8.0/8 | 0.0/10 | 10.0/10 | **69.3/100** |

## Study Forensics Audit

### Claude Opus

**Classification:** `solid` [+] (gold: `solid`)
**Finding Recall:** 50%
**Matched Findings:** cautious_scope_control
**Missed Findings:** evidence_matches_claim
**Extra Findings:** none_or_minor, conclusion_exceeds_results, unsupported_generalization, decorative_uncertainty, mechanism_not_demonstrated

## Reasoning Integrity Audit

### Claude Opus
**Classification:** Correct but brittle reasoning
**Load-bearing steps:** 0 / 7

## Mechanism Analysis

### Claude Opus
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :x: (0 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not described, mechanism not grounded to case data

## Grounding Audit

### Claude Opus
Conclusion claims: 1
- Direct support: 0
- Indirect support: 0
- Unsupported: 1
- Contradicted: 0

**Unsupported claims:**
- "solid"


## Forensic Flags

### Claude Opus

- **[MODERATE]** `weak_mechanism`: Correct answer but weak mechanism explanation — answer may not generalize
  - `final_answer`: "solid"
- **[MAJOR]** `unsupported_leap`: Correct answer with weak support chain — final answer may be an unsupported leap
- **[MODERATE]** `unsupported_conclusion_claims`: 1/1 conclusion claims lack step support
  - `final_answer`: "solid"
- **[MINOR]** `study_forensics_overflagging`: Agent raised extra findings in solid case: none_or_minor, conclusion_exceeds_results, unsupported_generalization, decorative_uncertainty, mechanism_not_demonstrated


## Evidence Map

### Claude Opus

**Correctness:** 30.0/30
  - (+) `final_answer`: "solid"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 0.0/8
  - (-) `final_answer`: "solid"
    _Conclusion not supported by steps_
  - Note: Support classification: 0 load-bearing, 0 supporting, 0 mentioned / 7
  - Note: Reasoning graph: conclusion not well grounded

**Structural Reasoning:** 4.8/8
  - (+) `steps[4]`: "Checked for spin: Investigators acknowledge cognitive benefits remain unproven despite biomarker success"
    _Most informative reasoning step_
  - Note: 7 reasoning steps
  - Note: Low step utility: 0/7 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[3]`: "The investigators' acknowledgment of unproven cognitive benefits is genuine"
    _Most substantive assumption_
  - Note: 4/4 substantive assumptions

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[0]`: "Whether the open-label extension proposal might constitute subtle optimism bias"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[2]`: "Whether 'proposed an open-label extension' implies unwarranted optimism"
    _Listed but never addressed in reasoning_
  - Note: 3 uncertainties (3 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[2]`: "Could be decorative_uncertainty if the acknowledgment was followed by strong therapeutic claims"
    _Most substantive alternative hypothesis_
  - Note: 3 alternative hypotheses considered
  - Note: 3/3 genuinely diverse alternatives

**Self Monitoring Quality:** 3.6/8
  - (+) `self_check[0]`: "Did I look for problems that aren't there? No - the text reports both successes and failures appropriately"
    _Most substantive self-verification step_
  - (-) `self_check[3]`: "The open-label extension is a standard next step, not an epistemic problem"
    _Fluff self-check_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 3 arithmetic, 1 fluff

**Mechanism Quality:** 0.0/10
  - Note: Neither names concept nor explains mechanism

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.74, 290 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Opus

**MODERATE:**
- **Unsupported Conclusion** `[MEDIUM CONFIDENCE]`: Final answer lacks load-bearing or supporting step grounding
  - `final_answer`: "solid"
  - _Impacts: support_strength_
- **Unsupported Intermediate Step** `[MEDIUM CONFIDENCE]`: No reasoning step is load-bearing — final answer lacks traceable derivation
  - `final_answer`: "solid"
  - _Impacts: support_strength, structural_reasoning_
- **Missed Key Insight** `[MEDIUM CONFIDENCE]`: Missed expected finding: evidence_matches_claim
  - `(task expectation)`: "Expected: evidence_matches_claim"
  - _Impacts: insight_depth_

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Whether 'proposed an open-label extension' implies unwarrant...' is listed but not addressed
  - `uncertainties[2]`: "Whether 'proposed an open-label extension' implies unwarranted optimism"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Opus

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/6 content words)
  - `key_claims[0]`: "This is a well-reported negative trial that acknowledges its primary failure"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/9 content words)
  - `key_claims[1]`: "The text maintains appropriate separation between biomarker success and clinical failure"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (0/7 content words)
  - `key_claims[2]`: "The acknowledgment that cognitive benefits remain unproven is epistemically sound"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 4 has low overlap with final answer (0/8 content words)
  - `key_claims[3]`: "No attempt to spin negative cognitive results into positive conclusions"
- **[WARN]** `[HEURISTIC]` `decorative_uncertainty`: Uncertainty 3 appears decorative — not addressed in reasoning or self-check
  - `uncertainties[2]`: "Whether 'proposed an open-label extension' implies unwarranted optimism"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "Could be mechanism_vs_evidence if biomarker improvements were presented as therapeutic success"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "Could be overclaim if the text implied cognitive benefits from biomarker changes"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 3 is stated without rejection reasoning
  - `alternative_hypotheses[2]`: "Could be decorative_uncertainty if the acknowledgment was followed by strong therapeutic claims"


## Agent Profiles

### Claude Opus (claude-opus-4-20250514)
**Parse OK:** True | **Latency:** 19157ms

**Final Answer:** solid

**Confidence:** 0.9

**Assumptions:**
- This is a Phase 2/3 trial with human participants
- The trial had cognitive decline as a primary or key endpoint
- The text accurately represents the study findings
- The investigators' acknowledgment of unproven cognitive benefits is genuine

**Reasoning Steps:**
1. Identified evidence tier: Phase 2/3 randomized trial in humans with inherited Alzheimer's = clinical_human tier
2. Identified conclusion tier: Text reports human trial results without extrapolating beyond them
3. Checked for bridge step: No bridge needed - conclusions match evidence tier
4. Evaluated claims: Text accurately reports both positive biomarker results AND negative cognitive outcomes
5. Checked for spin: Investigators acknowledge cognitive benefits remain unproven despite biomarker success
6. No overclaim detected: Text does not claim cognitive benefits despite biomarker improvements
7. No mechanism confusion: This is direct human evidence, not mechanistic speculation

**Key Claims:**
- This is a well-reported negative trial that acknowledges its primary failure
- The text maintains appropriate separation between biomarker success and clinical failure
- The acknowledgment that cognitive benefits remain unproven is epistemically sound
- No attempt to spin negative cognitive results into positive conclusions

**Alternative Hypotheses:**
- Could be mechanism_vs_evidence if biomarker improvements were presented as therapeutic success
- Could be overclaim if the text implied cognitive benefits from biomarker changes
- Could be decorative_uncertainty if the acknowledgment was followed by strong therapeutic claims

**Uncertainties:**
- Whether the open-label extension proposal might constitute subtle optimism bias
- The exact wording of how investigators 'emphasized' biomarker impacts
- Whether 'proposed an open-label extension' implies unwarranted optimism

**Self-Verification:**
- Did I look for problems that aren't there? No - the text reports both successes and failures appropriately
- Is this really solid? Yes - it's a human trial reporting human results with appropriate caveats
- Could the emphasis on biomarkers be problematic? No - as long as cognitive failure is acknowledged
- The open-label extension is a standard next step, not an epistemic problem

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 0.0/8 `..........`
- Structural Reasoning: 4.8/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 3.6/8 `####......`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 0.0/10 `..........`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Opus** scored **69.3/100**.

**Best per dimension:**
- Correctness: Claude Opus (30.0/30)
- Support Strength: Claude Opus (0.0/8)
- Structural Reasoning: Claude Opus (4.8/8)
- Assumption Discipline: Claude Opus (4.8/6)
- Uncertainty Handling: Claude Opus (3.6/6)
- Alternative Hypothesis Quality: Claude Opus (4.5/6)
- Self Monitoring Quality: Claude Opus (3.6/8)
- Insight Depth: Claude Opus (8.0/8)
- Mechanism Quality: Claude Opus (0.0/10)
- Communication Efficiency: Claude Opus (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Opus | 19.2s | 69.3/100 | 3.6 |

Failure modes observed: decorative_uncertainty, missed_key_insight, unsupported_conclusion, unsupported_intermediate_step.
